Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX18 Letermovir
D10801 Letermovir (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-cytomegalovirus (CMV) Agents
Letermovir
D10801 Letermovir (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D10801 Letermovir (JAN/USAN/INN)
Drug groups [BR:br08330]
Antiviral
DG01937 Anti-cytomegalovirus agent
D10801 Letermovir
Metabolizing enzyme inhibitor
DG02852 CYP3A/CYP3A4 inhibitor
D10801 Letermovir
Metabolizing enzyme inducer
DG02886 CYP2C9 inducer
D10801 Letermovir
DG02885 CYP2C19 inducer
D10801 Letermovir
Transporter substrate
DG02856 SLCO1B1 substrate
D10801 Letermovir
DG02932 SLCO1B3 substrate
D10801 Letermovir
Transporter inhibitor
DG02862 ABCG2 inhibitor
D10801 Letermovir
DG02865 SLCO1B1 inhibitor
D10801 Letermovir
DG02907 SLCO1B3 inhibitor
D10801 Letermovir
Drug classes [BR:br08332]
Antiviral
DG01937 Anti-cytomegalovirus agent
D10801 Letermovir
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Other inhibitor
D10801 Letermovir (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10801
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10801
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10801
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10801
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10801
Drug transporters
D10801